Oventus Medical Ltd (ASX: OVN) (Oventus, the Company) announces its Appendix 4C Report for the three-month period ending 31 December 2018 (Q2 FY2019) and is pleased to provide a review of progress made during the quarter.
For more information, please download the attached PDF.
Download this document
